Expleo Solutions Ltd. - Research Center
533121 EXPLEOSOL Group (B) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
| 15.52 |
15.52 |
10.25 |
10.25 |
10.25 |
Share application money
Preference share capital
Reserves & surplus
| 546.62 |
529.47 |
457.53 |
198.59 |
149.58 |
Secured loans
Unsecured loans
Total
| 562.14 |
544.99 |
473.65 |
208.97 |
159.96 |
Gross block
| 214.23 |
190.91 |
183.82 |
61.32 |
45.02 |
Less : revaluation reserve
Less : accumulated depreciation
| 102.39 |
60.64 |
43.68 |
22.31 |
20.35 |
Net block
| 111.84 |
130.27 |
140.14 |
39.01 |
24.68 |
Capital work-in-progress
Investments
| 3.48 |
19.38 |
4.02 |
4.02 |
4.02 |
Current assets, loans & advances
| 608.54 |
541.76 |
484.59 |
248.16 |
199.50 |
Less : current liabilities & provisions
| 161.72 |
150.96 |
161.15 |
82.22 |
68.23 |
Total net current assets
| 446.82 |
390.79 |
323.44 |
165.94 |
131.27 |
Miscellaneous expenses not written
Total
| 562.14 |
544.99 |
473.65 |
208.97 |
159.96 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
| 130.60 |
107.75 |
110.85 |
93.65 |
92.25 |
Number of equity sharesoutstanding (Lacs)
| 155.20 |
155.20 |
102.52 |
102.52 |
102.52 |